Form 4: Chemed Corp Director George J. Walsh III Acquires Shares
SEC Form 4 Filing
Director George J. Walsh III acquired 284 shares of Chemed Corp capital stock at $564.34 per share on May 20, 2024.
Summary
- On May 20, 2024, George J. Walsh III, a director of Chemed Corp, acquired 284 shares of the company's capital stock.
- The acquisition price was $564.34 per share.
- Following the transaction, Walsh directly owns 3,646 shares of Chemed Corp capital stock.
- Walsh's spouse indirectly owns 434 shares.
Sentiment
Score: 6
Explanation: The sentiment is neutral to slightly positive. A director purchasing shares suggests confidence, but it's a relatively small transaction.
Positives
- A director's purchase of company stock can be seen as a positive signal, indicating confidence in the company's future prospects.
Industry Context
Form 4 filings are a routine part of insider trading regulations, providing transparency into the transactions of company insiders. This specific transaction reflects the actions of a director at Chemed Corp.
Comparison to Industry Standards
- Insider transactions are common across publicly traded companies.
- Monitoring these transactions helps investors gauge sentiment among company leadership.
- Comparing the volume and frequency of insider transactions at Chemed Corp to its peers (e.g., LHC Group, Amedisys) can provide insights into relative management confidence.
Stakeholder Impact
- The transaction could have a minor positive impact on shareholder sentiment.
Key Dates
| Date | Description |
|---|---|
| 05/20/2024 | Date of stock acquisition by George J. Walsh III |
| 05/21/2024 | Date of signature on the report |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.